Trial intelligence / Profile preview

Toremifene vs Anastrozole Adjuvant Therapy in Breast Cancer

NCT00437359Phase 2Terminated

Sponsor
Japan Breast Cancer Research Network
Start
May 2007
Primary completion
May 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of toremifene in breast cancer, sponsored by Japan Breast Cancer Research Network. Started May 2007; status: terminated.

02

Drugs

toremifene
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00437359.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00437359.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call